These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34825627)

  • 1. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting.
    Patel P; Raval M; Airao V; Bhatt V; Shah P
    J Microencapsul; 2022 Jan; 39(1):1-24. PubMed ID: 34825627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study.
    Patel P; Raval M; Manvar A; Airao V; Bhatt V; Shah P
    PLoS One; 2022; 17(5):e0267257. PubMed ID: 35560136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannosylated Solid Lipid Nanocarriers of Chrysin to Target Gastric Cancer: Optimization and Cell Line Study.
    Pandey SS; Shaikh FI; Gupta AR; Vaidya RJ
    Curr Drug Deliv; 2021; 18(10):1574-1584. PubMed ID: 33745434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery.
    Patel P; Raval M; Airao V; Ali N; Shazly GA; Khan R; Prajapati B
    ACS Omega; 2024 Mar; 9(9):10353-10370. PubMed ID: 38463259
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
    Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
    Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
    Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of solid lipid nanoparticles containing silibinin.
    Zhang JQ; Liu J; Li XL; Jasti BR
    Drug Deliv; 2007 Aug; 14(6):381-7. PubMed ID: 17701527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations.
    Daneshmand S; Jaafari MR; Movaffagh J; Malaekeh-Nikouei B; Iranshahi M; Seyedian Moghaddam A; Tayarani Najaran Z; Golmohammadzadeh S
    Colloids Surf B Biointerfaces; 2018 Apr; 164():332-339. PubMed ID: 29413613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticle: A potent vehicle of the kaempferol for brain delivery through the blood-brain barrier in the focal cerebral ischemic rat.
    Ghosh A; Khanam N; Nath D
    Chem Biol Interact; 2024 Jul; 397():111084. PubMed ID: 38823537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation.
    Zewail MB; F Asaad G; Swellam SM; Abd-Allah SM; K Hosny S; Sallah SK; E Eissa J; S Mohamed S; El-Dakroury WA
    Int J Pharm; 2022 Aug; 624():122006. PubMed ID: 35820515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment.
    Paul PK; Nakpheng T; Paliwal H; Prem Ananth K; Srichana T
    Int J Pharm; 2024 Jul; 660():124309. PubMed ID: 38848797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels.
    El-Emam GA; Girgis GNS; Hamed MF; El-Azeem Soliman OA; Abd El Gawad AEGH
    Int J Nanomedicine; 2021; 16():7775-7799. PubMed ID: 34853513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
    Sharma JB; Bhatt S; Saini V; Kumar M
    Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
    [No Abstract]   [Full Text] [Related]  

  • 18. Glyceryl Monostearate based Solid Lipid Nanoparticles for Controlled Delivery of Docetaxel.
    Rai N; Madni A; Faisal A; Jamshaid T; Khan MI; Khan MM; Parveen F
    Curr Drug Deliv; 2021; 18(9):1368-1376. PubMed ID: 33538673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.